COVID-19 pandemic
The Belgian government finalizes an agreement to buy 20,000 courses of Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug.
Sources: The Brussels Times
Changes
- The Belgian government finalizes an agreement to buy 20,000 courses of anti-COVID-19 pills developed by two drugmakers, Paxlovid by Pfizer and Molnupiravir by Merck & Co..
- The Belgian government finalizes an agreement to buy 20,000 courses of Pfizer's Paxlovid COVID-19 drug and Merck & Co.'s Molnupiravir COVID-19 drug.